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and thapsigargin was attenuated by AICAR in articular chondro-
cytes.
Conclusions: Certain inﬂammatory stimuli suppress AMPK ac-
tivation in articular chondrocytes. Moreover, AMPKα knockdown
by RNAi enhances pro-catabolic responses of articular chon-
drocytes. Conversely, pharmacologic AMPK activation attenuates
articular chondrocyte pro-catabolic and hypertrophic differentiation
responses to inﬂammatory cytokines and alleviates the ER stress
response. Because human OA knee articular chondrocytes ex-
hibited attenuated AMPKα activation, our results provide the ﬁrst
evidence that therapeutic activation of AMPK has the potential to
inhibit the progression of OA.
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SELENOMETHIONINE INHIBITS IL-1β INDUCED NITRIC
OXIDE SYNTHASE (INOS) AND CYCLOOXYGENASE 2
(COX2) IN PRIMARY HUMAN CHONDROCYTES
W.M. Cheng, T.V. Stabler, M. Bolognesi, V.B. Kraus
Duke Univ., Durham, NC
Purpose: Inﬂammatory cytokine Interleukin-1 (IL-1β) stimulates
reactive oxygen species (ROS), which mediates downstream cell
signaling, modulating catabolic and inﬂammatory gene expression
such as inducible nitric oxide synthase (iNOS) and cyclooxygenase
2 (COX2). The nutritional and antioxidant factor selenium (Se), has
long been considered to play an important role in Osteoarthritis
(OA). The ability of Se to neutralize reactive oxygen and nitrogen
species is one potential chondroprotective mechanism against OA
progression. In this study, we test if Se can neutralize inﬂammatory
and catabolic effects of IL-1β and examine the common signaling
pathways involved.
Methods: Primary chondrocytes and treatment. Primary human
chondrocytes were isolated by enzymatic digestion as previously
described from nonlesional cartilage of patients undergoing total
knee replacement surgery. Chondrocytes were pretreated with
and without 0.5 μM SelenoMethionine (SeMet) for 24 hrs and then
followed by 50 pg/ml or 100 pg/ml 1L-1β treatment for up to 24
hrs.
RNA isolation and Real Time RT-PCR. Total RNA was extracted
and reverse transcribed into cDNA for Real Time RT-PCR analy-
sis. The ABI Prism 7000 sequence detection system and relative
quantiﬁcation software (Applied Biosystems, Foster City, CA) were
used for real-time analyses. Analysis of relative mRNA expression
levels of iNOS and COX2 were normalized to 18S gene expres-
sion. Values are the mean (SEM) percentage as a percentage of
IL-1β induced iNOS and COX2 mRNA levels for three independent
experiments, conducted in triplicate. The relative mRNA level in
cells treated with IL-1β alone was set at 100%.
Immunoblotting and Phosphorylation Assay. Whole cell lysates
from chondrocytes for each tested condition were separated by
electrophoresis on reducing gradient gels, and transferred to ni-
trocellulose for immunoblotting. Membranes were blocked with 5%
BSA in TBS/0.1% Tween 20 (TBS-T). Polyclonal primary antibod-
ies against Phospho-p44/42 MAPK 3(Erk1/2), Phospho-p38 MAPK
(Thr180/Tyr182), Phospho-SAPK/JNK (Thr183/Tyr185), Phospho-
IKKα/β (Ser 176/180) Phospho- NF-kB p65 (Ser 536) were ob-
tained from Cell Signaling Technology (Danvers, MA) and used
at 1:1000 dilution. A monoclonal antibody against tubulin (Sigma)
was used as a normalization control at 1:10,000 dilution. Anti-
rabbit and anti-mouse IgG-HRP (Jackson ImmunoResearch, West
Grove, PA) secondary antibodies were diluted 1:50,000. The re-
sults shown are representative of two independent experiments,
conducted in duplicate.
Results: Pretreatment of chondrocytes with SeMet signiﬁcantly
inhibited the IL-1β induced iNOS gene expression (by ∼30%) and
COX2 gene expression (by ∼40%), Figure 1. Furthermore, SeMet
Figure 1. Pretreatment of SeMet inhibits IL-1β induced iNOS and COX2 mRNA
levels.
Figure 2. The effect of selenium pretreatment on the IL-1β induced signaling
pathways.
selectively inhibited IL-1β activated p38 MAPK and NF-kB activity,
but not JNK, ERK and IKKα/β activity (Figure 2, Western blot).
Conclusions: Taken together, our data show that Se can partially
reverse IL-1β induced iNOS and COX2 gene expression, and
shows evidence of altering IL-1β activated cell signaling. These
results suggest that one mechanism by which Se may exert a
chondroprotective effect is through regulation of cell signaling
pathways induced by pro-inﬂammatory cytokines.
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CHONDROCYTE PHENOTYPE IS DETERMINANT FOR THE
EXPRESSION OF ADIPOKINES AND THEIR RECEPTORS
P.-J. Francin, A.-C. Humbert, C. Guillaume, P. Pottie, B. Terlain,
P. Netter, D. Mainard, N. Presle
UMR 7561 CNRS-Nancy Univ., Vandoeuvre les Nancy, France
Purpose: As adiposity rather than simply excess in body mass
has been shown to be detrimental to the knee joint, increasing
studies have been undertaken to determine the role of adipokines
in osteoarthritis (OA). However, contradictory data have been
found for the expression and the effects of these adipose-derived
proteins in chondrocytes. This study investigated therefore the
effects of phenotypic modulation on the expression of adipokines
and their receptors in human chondrocytes.
Methods: The expression of adipokines (leptin and adiponectin)
and their receptors (AdipoR1, AdipoR2 and Ob-R) was examined
by quantitative real-time RT-PCR in chondrocytes obtained from
patients with osteoarthritis (OA) either directly after cells harvest
or after culture in monolayer or in alginate bead which is known
to restore and/or maintain the differentiated state of chondrocytes.
The change in transcript level of collagens type 1, 2A and 2B,
aggrecan and Sox9 was used to evaluate phenotypic modulation.
Results: The results indicated that leptin, adiponectin, AdipoR1
and Ob-R were expressed in freshly isolated chondrocytes while
AdipoR2 was barely detected. Major changes in the gene expres-
sion pattern occurred after culture in monolayer with a shift from
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the adipokines to their receptors. Interestingly, the downregulation
of adipokines was associated with the reduced expression of the
cartilage-speciﬁc transcription factor Sox9 and a strong increase
in the transcript level of collagen type 1. Chondrocytes recovered
a cartilage-like expression proﬁle of leptin and adiponectin when
cultured in alginate beads, but ceased expressing their receptors.
Conclusions: The modulation of chondrocyte phenotype induced
by experimental conditions affects the expression of adipokines
and their receptors. These experiment-dependent changes could
result in modiﬁcations of cell response to leptin or adiponectin, and
could therefore contribute to the discrepancies found in different
studies. These ﬁndings suggest also that adipokines may play an
essential role to prevent a phenotypic loss of chondrocyte function.
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AUTOPHAGY: A NEW TARGET IN THE HUMAN
OSTEOARTHRITIC CARTILAGE
M.C. de Andres, C. Ruiz-Romero, V. Calamia, J. Mateos,
F. Galdo, F.J. Blanco
Osteoarticular and Aging Res. Lab. Rheumatology Div.,
INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain
Purpose: There is considerable evidence to suggest that pro-
grammed cell death (PCD) is not conﬁned to apoptosis and that
other mechanisms may also operate. One of these mechanisms
is the so-called “autophagic PCD”. Previously, some authors ob-
served that chondrocytes in OA cartilage demonstrated morpho-
logic changes that are characteristic features of apoptosis; how-
ever, we have observed the increase in autophagic levels in OA
cultured chondrocytes compared to normal cultured chondrocytes.
On the other hand, levels of microtubule-associated protein light
chain 3 (LC3), speciﬁcally LC3-II, is clearly correlated with the
number of autophagosomes.
The objective is to asses the levels of autophagy in normal and
OA human articular cartilage.
Methods: Normal and osteoarthritic (OA) human cartilages were
obtained from patients with joint replacement (femoral and knee
joint) and from autopsy cases (knee joint). To carry out studies
with cartilage, some pieces were frozen and subsequently pulver-
ized and other ones were cryopreserved until histologic studies
were done. The expression of the AuTophaGy-related (ATG) gen
LC-3 was assessed by means of western-blot and immunohisto-
chemistry using a speciﬁc policlonal antibody (Abcam, UK). Values
obtained by western-blot were normalized by means of α-tubuline
expression and the changes in this expression were measured us-
ing the ImageQuant (Version 5.2) program. On the other hand, 30
μg of cartilage extract was resolved using 2-DE; wide pH range
(nonlinear 3-10) was used for ﬁrst dimension and small format
polyacrylamide gels for the second dimension. The MS-compatible
silver staining was performed. The samples were analyzed using
the MALDI-TOF/TOF mass spectrometer 4700 Proteomics Ana-
lyzer (Applied Biosystems, Framingham, MA, USA).
Results: The study of LC-3 expression by means of western-
blot showed that OA human cartilage has higher expression of
LC3-II compared with normal cartilage (ratio >2). Densitometric
analysis was carried out by Image-Quant software. These ﬁndings
were corroborated with an immunohistochemistry study. On the
other hand, some autophagy-related proteins were identiﬁed by
means of MALDI-TOF/TOF mass spectrometer: lysozyme and
phospolipase; in both cases, the levels of these proteins were
signiﬁcantly higher in OA samples.
Conclusions: These results show the increase in autophagic
levels in OA human cartilage compared to normal human carti-
lage, conﬁrming the previous results with chondrocyte cultures.
The autophagy increase could contribute to the development and
progression of articular cartilage degeneration.
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HEME OXYGENASE-1 REGULATES INFLAMMATORY
MEDIATORS IN CARTILAGE ADJACENT TO SUBCHONDRAL
BONE FROM OSTEOARTHRITIC PATIENTS
V. Clérigues1, F. Gomar2, M. Alcaraz1, I. Guillén1,3
1Univ. of Valencia, Dept. Pharmacology, Burjasot, Spain; 2Univ. of
Valencia, Dept. Surgery, Valencia, Spain; 3Cardenal Herrera-CEU
Univ., Moncada, Spain
Purpose: Osteoarthritis (OA) produces articular degeneration
manifested by changes in the cartilage and subchondral bone.
Previously, we reported that heme oxygenase-1 (HO-1) is down-
regulated by catabolic factors in superﬁcial chondrocytes. The
function of these chondrocytes can be modulated by the cells
present in deeper zones including calciﬁed cartilage and subchon-
dral bone. The aim of the present work was to study the possible
protective effects of HO-1 against inﬂammatory mediators in this
area.
Methods: Osteochondral explants (including cartilage and sub-
chondral bone) of 3.5 mm of diameter were obtained from 10 pa-
tients with diagnosis of advanced OA undergoing total knee joint
replacement. Explants were maintained for 24h with DMEM/F12
and antibiotic and then stimulated with IL-1β (100 U/ml) and/or
the HO-1 inducer cobalt protoporphyrin IX (CoPP) during 72h.
Samples of culture medium were taken to measure prostaglandin
E2 (PGE2) by RIA and nitrite by a ﬂuorometric method. Tissue
explants were included in formalin (10%) for histological and im-
munohistological determinations. Cellular viability (evaluated by
the LDH method) and phenotype (collagen II expression) were
maintained throughout the culture period.
Results: We have shown by immunohistological analysis of ex-
plants that HO-1 and telomerase are predominantly expressed
in chondrocytes in the area next to subchondral bone. This ex-
pression was down-regulated in the presence of IL-1β. Besides,
this pro-inﬂammatory cytokine increased nitric oxide synthase-2
(NOS-2), cyclo-oxygenase-2 (COX-2) and high mobility group box
1 (HMGB1) expression in the same cells, as well as the levels
of nitrite and PGE2 in the culture medium. Induction of HO-1 by
CoPP reverted the effects of IL-1β on telomerase expression. In
addition, we observed a signiﬁcant decrease in NOS-2, COX-2
and HMGB1 expression by HO-1 up-regulation, accompanied by
reductions in the levels of corresponding metabolites.
Conclusions: In this work, we have shown a correlation be-
tween HO-1 and telomerase expression in chondrocytes adjacent
to subchondral bone, accompanied by inhibition of inﬂammatory
mediators. These results support the view that HO-1 may be a
potential target for cartilage regeneration and repair.
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REGULATION OF OSTEOARTHRITIC CHONDROCYTES BY
GROWTH AND DIFFERENTIATION FACTOR 5
P. Lavigne, J.-M. Brunet-Maheu, Q. Shi, M. Benderdour
Univ. of Montreal, Montreal, QC, Canada
Purpose: Genetic studies have identiﬁed osteoarthritis (OA) sus-
ceptibility genes that are present across different populations.
Interestingly, a majority of them are involved in developmental
processes and/or maintenance of cartilage and bone homeosta-
sis. Amongst these conﬁrmed susceptibility genes is growth and
differentiation factor (GDF) -5. Early in life, GDF-5 is an important
mediator of skeletal formation. However, little is known about the
physiologic role of this protein in adults and despite its genetic
association with OA, potential implication of GDF-5 protein in this
disease remains unknown. Therefore, the main objective of this
study is to assess the effect of rhGDF-5 on OA human and ca-
